Search results
iTeos Therapeutics and GSK begin Phase III trial of combination therapy for NSCLC
Clinical Trials Arena via Yahoo Finance· 6 days agoiTeos Therapeutics and GSK have begun the GALAXIES Lung-301 Phase III clinical trial of belrestotug...
The evolution of contract packagers: delivering sustainability for injectables packaging
Pharmaceutical Technology via Yahoo Finance· 1 hour agoInjectable drug products have transformed human health, but at what cost to the environment? Now,...
Industry groups back drugmakers' appeal in Zantac cancer lawsuits
Reuters via Yahoo News· 4 days agoA bid by GSK and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued...
Industry Groups Back Drugmakers' Appeal in Zantac Cancer Lawsuits
Insurance Journal· 4 days agoA bid by GSK and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued...
Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs - Innoviva (NASDAQ:INVA)
Benzinga· 6 days agoCantor Fitzgerald has initiated coverage on Innoviva, Inc. INVA, citing the company’s unique...
Health Care Roundup: Market Talk
The Wall Street Journal· 4 days agoPublished exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 1212 ET – GSK is betting on AI to boost innovation for its pipeline as...
Major drug companies cap asthma medication costs at $35 per month
WISN 12 Milwaukee· 3 days agoMajor pharmaceutical companies have agreed to cap out-of-pocket costs for some asthma patients at...
Health Care Roundup: Market Talk
The Wall Street Journal· 4 days agoFind insight on GSK, Top Glove, ResMed and more in the latest Market Talks covering the Health Care sector.
As big pharma exits Nigeria, asthma patients face spiralling costs
Al Jazeera· 5 days agoWhen Gloria Mofifoluwa’s friend informed her in March that the price of inhalers had risen in...
Industry groups back drugmakers' appeal in Zantac cancer lawsuits
Reuters· 4 days ago, opens new tab and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued...